A detailed history of Norinchukin Bank, The transactions in Merck & Co., Inc. stock. As of the latest transaction made, Norinchukin Bank, The holds 113,846 shares of MRK stock, worth $11.2 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares
113,846
Previous 99,287 14.66%
Holding current value
$11.2 Million
Previous $12.3 Million 5.18%
% of portfolio
0.31%
Previous 0.36%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$111.15 - $128.97 $1.62 Million - $1.88 Million
14,559 Added 14.66%
113,846 $12.9 Million
Q2 2024

Aug 14, 2024

BUY
$123.8 - $132.96 $48,901 - $52,519
395 Added 0.4%
99,287 $12.3 Million
Q1 2024

May 14, 2024

SELL
$113.24 - $131.95 $453,299 - $528,195
-4,003 Reduced 3.89%
98,892 $13 Million
Q4 2023

Feb 13, 2024

SELL
$100.18 - $109.02 $1.15 Million - $1.25 Million
-11,476 Reduced 10.03%
102,895 $11.2 Million
Q3 2023

Nov 13, 2023

BUY
$102.95 - $114.33 $11.8 Million - $13.1 Million
114,371 New
114,371 $11.8 Million
Q2 2023

Aug 14, 2023

BUY
$108.61 - $118.38 $5.74 Million - $6.26 Million
52,869 Added 29.38%
232,844 $26.9 Million
Q1 2023

May 12, 2023

BUY
$102.94 - $114.86 $493,803 - $550,983
4,797 Added 2.74%
179,975 $19.1 Million
Q4 2022

Feb 13, 2023

SELL
$87.44 - $112.11 $3.38 Million - $4.33 Million
-38,653 Reduced 18.08%
175,178 $19.4 Million
Q3 2022

Nov 14, 2022

BUY
$84.53 - $94.96 $1.74 Million - $1.95 Million
20,582 Added 10.65%
213,831 $18.4 Million
Q2 2022

Aug 10, 2022

SELL
$83.49 - $94.64 $5.5 Million - $6.23 Million
-65,878 Reduced 25.42%
193,249 $17.6 Million
Q1 2022

May 12, 2022

BUY
$73.51 - $82.4 $1.23 Million - $1.37 Million
16,674 Added 6.88%
259,127 $21.3 Million
Q4 2021

Feb 10, 2022

SELL
$72.28 - $90.54 $325,043 - $407,158
-4,497 Reduced 1.82%
242,453 $18.6 Million
Q3 2021

Nov 09, 2021

BUY
$71.68 - $78.83 $740,239 - $814,077
10,327 Added 4.36%
246,950 $18.5 Million
Q2 2021

Aug 11, 2021

BUY
$70.31 - $77.77 $308,449 - $341,176
4,387 Added 1.89%
236,623 $18.4 Million
Q1 2021

May 12, 2021

BUY
$68.86 - $81.11 $39,938 - $47,043
580 Added 0.25%
232,236 $17.9 Million
Q4 2020

Feb 12, 2021

SELL
$71.77 - $79.65 $357,845 - $397,134
-4,986 Reduced 2.11%
231,656 $18.9 Million
Q3 2020

Nov 12, 2020

BUY
$73.18 - $82.95 $157,995 - $179,089
2,159 Added 0.92%
236,642 $19.6 Million
Q2 2020

Aug 12, 2020

SELL
$70.42 - $80.13 $1.47 Million - $1.68 Million
-20,912 Reduced 8.19%
234,483 $18.1 Million
Q1 2020

May 13, 2020

SELL
$63.36 - $87.82 $13.3 Million - $18.4 Million
-209,408 Reduced 45.05%
255,395 $19.7 Million
Q4 2019

Feb 12, 2020

SELL
$77.58 - $87.54 $2.07 Million - $2.33 Million
-26,634 Reduced 5.42%
464,803 $42.3 Million
Q3 2019

Nov 12, 2019

BUY
$76.08 - $82.93 $567,480 - $618,574
7,459 Added 1.54%
491,437 $41.4 Million
Q2 2019

Aug 09, 2019

SELL
$69.84 - $81.59 $13 Million - $15.1 Million
-185,479 Reduced 27.71%
483,978 $40.6 Million
Q1 2019

May 10, 2019

SELL
$69.58 - $79.36 $481,215 - $548,853
-6,916 Reduced 1.02%
669,457 $55.7 Million
Q4 2018

Feb 08, 2019

BUY
$65.24 - $75.71 $4.13 Million - $4.79 Million
63,332 Added 10.33%
676,373 $51.7 Million
Q3 2018

Nov 08, 2018

BUY
$57.69 - $67.84 $10,672 - $12,550
185 Added 0.03%
613,041 $43.5 Million
Q2 2018

Aug 10, 2018

BUY
$50.83 - $59.72 $4.66 Million - $5.47 Million
91,595 Added 17.57%
612,856 $37.2 Million
Q1 2018

May 10, 2018

BUY
$50.96 - $59.23 $3.5 Million - $4.07 Million
68,728 Added 15.19%
521,261 $28.4 Million
Q4 2017

Feb 09, 2018

BUY
$51.62 - $61.64 $3.99 Million - $4.76 Million
77,221 Added 20.58%
452,533 $25.5 Million
Q3 2017

Nov 08, 2017

BUY
$58.67 - $63.13 $22 Million - $23.7 Million
375,312
375,312 $24 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $248B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Norinchukin Bank, The Portfolio

Follow Norinchukin Bank, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norinchukin Bank, The, based on Form 13F filings with the SEC.

News

Stay updated on Norinchukin Bank, The with notifications on news.